![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 03, 2020 11:50:11 PM
In that both of our products are in Phase 3 Trials they've clearly proven themselves safe, and have efficacy worthy of running Phase 3 Trials. I believe that should put us in the lead, even if they're first to dose in the U.S. We're dosing in Israel, and may be in Germany, or will be soon.
If you look at the curves, by mid April we'll be near the peak in most of the forecast curves, basically from what I've seen by June the numbers really come down substantially. If we really want to cut the number of deaths, if initial trials look good, we need to get the worlds govts. to go for treatment with it by May. Here's a link to the best data I've seen for the U.S.
https://covid19.healthdata.org/projections
Our drug won't prevent getting infected with the disease, but if it's effective it can greatly reduce the deaths, and should greatly diminish the need to put people on regulators.
Gary
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM